Structure

Physi-Chem Properties

Molecular Weight:  456.29
Volume:  489.387
LogP:  3.32
LogD:  2.743
LogS:  -3.923
# Rotatable Bonds:  5
TPSA:  77.51
# H-Bond Aceptor:  5
# H-Bond Donor:  0
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.339
Synthetic Accessibility Score:  5.312
Fsp3:  0.786
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.816
MDCK Permeability:  1.4047274817130528e-05
Pgp-inhibitor:  0.99
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.027
20% Bioavailability (F20%):  0.015
30% Bioavailability (F30%):  0.716

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.982
Plasma Protein Binding (PPB):  55.56798553466797%
Volume Distribution (VD):  2.511
Pgp-substrate:  44.85578918457031%

ADMET: Metabolism

CYP1A2-inhibitor:  0.009
CYP1A2-substrate:  0.103
CYP2C19-inhibitor:  0.015
CYP2C19-substrate:  0.158
CYP2C9-inhibitor:  0.016
CYP2C9-substrate:  0.032
CYP2D6-inhibitor:  0.05
CYP2D6-substrate:  0.11
CYP3A4-inhibitor:  0.833
CYP3A4-substrate:  0.294

ADMET: Excretion

Clearance (CL):  8.21
Half-life (T1/2):  0.137

ADMET: Toxicity

hERG Blockers:  0.013
Human Hepatotoxicity (H-HT):  0.073
Drug-inuced Liver Injury (DILI):  0.137
AMES Toxicity:  0.058
Rat Oral Acute Toxicity:  0.41
Maximum Recommended Daily Dose:  0.958
Skin Sensitization:  0.953
Carcinogencity:  0.217
Eye Corrosion:  0.98
Eye Irritation:  0.296
Respiratory Toxicity:  0.979

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC274417

Natural Product ID:  NPC274417
Common Name*:   12Alpha-Acetoxy-24-Methyl-24-Oxoscalar-16-En-22,25-Dial
IUPAC Name:   [(4aR,4bS,6S,6aS,7R,10aS,10bS,12aS)-8-acetyl-4a,7-diformyl-1,1,6a,10b-tetramethyl-2,3,4,4b,5,6,7,10,10a,11,12,12a-dodecahydrochrysen-6-yl] acetate
Synonyms:  
Standard InCHIKey:  YRTZXBPLXPUTPV-GPWSRLOJSA-N
Standard InCHI:  InChI=1S/C28H40O5/c1-17(31)19-8-9-22-26(5)13-10-21-25(3,4)11-7-12-28(21,16-30)23(26)14-24(33-18(2)32)27(22,6)20(19)15-29/h8,15-16,20-24H,7,9-14H2,1-6H3/t20-,21-,22-,23-,24-,26-,27+,28+/m0/s1
SMILES:  O=C[C@H]1C(=CC[C@@H]2[C@]1(C)[C@@H](OC(=O)C)C[C@H]1[C@@]2(C)CC[C@@H]2[C@]1(C=O)CCCC2(C)C)C(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL510804
PubChem CID:   23425818
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001552] Sesterterpenoids
          • [CHEMONTID:0002883] Scalarane sesterterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33170 lendenfeldia chondrodes Species Thorectidae Eukaryota n.a. palauan n.a. PMID[9917306]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT3973 Individual Protein Endothelial PAS domain-containing protein 1 Homo sapiens EC50 = 4200.0 nM PMID[524770]
NPT5842 Organism Mytilus edulis Mytilus edulis Activity = 10.0 % PMID[524769]
NPT5842 Organism Mytilus edulis Mytilus edulis Activity = 55.0 % PMID[524769]
NPT5842 Organism Mytilus edulis Mytilus edulis Activity = 75.0 % PMID[524769]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC274417 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9886 High Similarity NPC269729
0.9565 High Similarity NPC475202
0.9565 High Similarity NPC475385
0.9565 High Similarity NPC475392
0.9545 High Similarity NPC328141
0.9263 High Similarity NPC282233
0.9263 High Similarity NPC95585
0.9 High Similarity NPC469546
0.8913 High Similarity NPC474185
0.8842 High Similarity NPC471966
0.883 High Similarity NPC469545
0.883 High Similarity NPC5532
0.883 High Similarity NPC61369
0.8764 High Similarity NPC2709
0.8737 High Similarity NPC473456
0.8737 High Similarity NPC226986
0.871 High Similarity NPC79117
0.8696 High Similarity NPC159748
0.8696 High Similarity NPC101651
0.8681 High Similarity NPC224145
0.8636 High Similarity NPC470813
0.8632 High Similarity NPC471039
0.8617 High Similarity NPC471040
0.8617 High Similarity NPC74751
0.8602 High Similarity NPC230064
0.8571 High Similarity NPC162107
0.8571 High Similarity NPC30421
0.8571 High Similarity NPC46912
0.8542 High Similarity NPC292133
0.8542 High Similarity NPC23680
0.8526 High Similarity NPC139570
0.8511 High Similarity NPC295643
0.8511 High Similarity NPC272075
0.8511 High Similarity NPC214756
0.8511 High Similarity NPC151722
0.8485 Intermediate Similarity NPC254202
0.8478 Intermediate Similarity NPC474925
0.8478 Intermediate Similarity NPC474845
0.8462 Intermediate Similarity NPC471042
0.8462 Intermediate Similarity NPC91525
0.8462 Intermediate Similarity NPC9892
0.8462 Intermediate Similarity NPC329943
0.8462 Intermediate Similarity NPC10005
0.8454 Intermediate Similarity NPC478056
0.8409 Intermediate Similarity NPC474956
0.8404 Intermediate Similarity NPC233455
0.8404 Intermediate Similarity NPC145067
0.8404 Intermediate Similarity NPC65120
0.8404 Intermediate Similarity NPC4036
0.8404 Intermediate Similarity NPC218301
0.8404 Intermediate Similarity NPC158030
0.84 Intermediate Similarity NPC189616
0.8387 Intermediate Similarity NPC475049
0.8387 Intermediate Similarity NPC477973
0.8367 Intermediate Similarity NPC104861
0.8351 Intermediate Similarity NPC26413
0.8351 Intermediate Similarity NPC89225
0.8333 Intermediate Similarity NPC139459
0.83 Intermediate Similarity NPC179208
0.83 Intermediate Similarity NPC36321
0.83 Intermediate Similarity NPC478057
0.8298 Intermediate Similarity NPC291028
0.8298 Intermediate Similarity NPC152467
0.8298 Intermediate Similarity NPC113989
0.8298 Intermediate Similarity NPC120840
0.8298 Intermediate Similarity NPC474842
0.8298 Intermediate Similarity NPC474728
0.8298 Intermediate Similarity NPC475965
0.8283 Intermediate Similarity NPC310981
0.828 Intermediate Similarity NPC206060
0.828 Intermediate Similarity NPC473229
0.8265 Intermediate Similarity NPC194196
0.8265 Intermediate Similarity NPC176845
0.8247 Intermediate Similarity NPC122324
0.8247 Intermediate Similarity NPC106425
0.8247 Intermediate Similarity NPC151725
0.8247 Intermediate Similarity NPC111684
0.8247 Intermediate Similarity NPC58052
0.8247 Intermediate Similarity NPC167193
0.8247 Intermediate Similarity NPC472806
0.8247 Intermediate Similarity NPC98874
0.8229 Intermediate Similarity NPC159410
0.8229 Intermediate Similarity NPC470697
0.8229 Intermediate Similarity NPC474529
0.8229 Intermediate Similarity NPC169751
0.8229 Intermediate Similarity NPC272635
0.8222 Intermediate Similarity NPC163236
0.8218 Intermediate Similarity NPC470297
0.8211 Intermediate Similarity NPC470590
0.8211 Intermediate Similarity NPC77099
0.8211 Intermediate Similarity NPC105189
0.8211 Intermediate Similarity NPC60755
0.8211 Intermediate Similarity NPC285184
0.82 Intermediate Similarity NPC136289
0.8191 Intermediate Similarity NPC184663
0.8191 Intermediate Similarity NPC30522
0.8191 Intermediate Similarity NPC50070
0.8163 Intermediate Similarity NPC476768
0.8163 Intermediate Similarity NPC38530
0.8163 Intermediate Similarity NPC170131
0.8163 Intermediate Similarity NPC84335
0.8155 Intermediate Similarity NPC189075
0.8155 Intermediate Similarity NPC275539
0.8144 Intermediate Similarity NPC148523
0.8125 Intermediate Similarity NPC49776
0.8125 Intermediate Similarity NPC294263
0.8125 Intermediate Similarity NPC474436
0.8125 Intermediate Similarity NPC86368
0.8125 Intermediate Similarity NPC298554
0.8125 Intermediate Similarity NPC476416
0.8125 Intermediate Similarity NPC107674
0.8125 Intermediate Similarity NPC141497
0.8125 Intermediate Similarity NPC63118
0.8125 Intermediate Similarity NPC170220
0.8119 Intermediate Similarity NPC264048
0.8119 Intermediate Similarity NPC95899
0.8119 Intermediate Similarity NPC275583
0.8111 Intermediate Similarity NPC475665
0.8105 Intermediate Similarity NPC273621
0.8105 Intermediate Similarity NPC227467
0.8105 Intermediate Similarity NPC290614
0.8105 Intermediate Similarity NPC210037
0.8105 Intermediate Similarity NPC477872
0.8105 Intermediate Similarity NPC7260
0.8105 Intermediate Similarity NPC120968
0.8105 Intermediate Similarity NPC193750
0.8105 Intermediate Similarity NPC18872
0.81 Intermediate Similarity NPC81530
0.8085 Intermediate Similarity NPC472802
0.8085 Intermediate Similarity NPC80335
0.8085 Intermediate Similarity NPC40552
0.8085 Intermediate Similarity NPC246708
0.8085 Intermediate Similarity NPC182797
0.8085 Intermediate Similarity NPC52169
0.8081 Intermediate Similarity NPC260149
0.8081 Intermediate Similarity NPC58942
0.8081 Intermediate Similarity NPC188833
0.8077 Intermediate Similarity NPC310546
0.8077 Intermediate Similarity NPC112457
0.8068 Intermediate Similarity NPC472300
0.8065 Intermediate Similarity NPC195640
0.8065 Intermediate Similarity NPC325594
0.8065 Intermediate Similarity NPC73038
0.8065 Intermediate Similarity NPC220478
0.8061 Intermediate Similarity NPC327179
0.8061 Intermediate Similarity NPC471775
0.8061 Intermediate Similarity NPC192428
0.8061 Intermediate Similarity NPC219353
0.8058 Intermediate Similarity NPC220974
0.8058 Intermediate Similarity NPC110496
0.8043 Intermediate Similarity NPC470812
0.8043 Intermediate Similarity NPC312660
0.8041 Intermediate Similarity NPC476415
0.8041 Intermediate Similarity NPC78580
0.8041 Intermediate Similarity NPC471207
0.8041 Intermediate Similarity NPC222047
0.8041 Intermediate Similarity NPC23621
0.8041 Intermediate Similarity NPC184006
0.8041 Intermediate Similarity NPC209868
0.8041 Intermediate Similarity NPC294266
0.8041 Intermediate Similarity NPC296164
0.8022 Intermediate Similarity NPC286786
0.8022 Intermediate Similarity NPC142683
0.8021 Intermediate Similarity NPC470230
0.8021 Intermediate Similarity NPC187722
0.8021 Intermediate Similarity NPC212301
0.8021 Intermediate Similarity NPC297265
0.8021 Intermediate Similarity NPC474525
0.8021 Intermediate Similarity NPC86266
0.8021 Intermediate Similarity NPC38754
0.8021 Intermediate Similarity NPC110657
0.802 Intermediate Similarity NPC40918
0.8 Intermediate Similarity NPC225585
0.8 Intermediate Similarity NPC267517
0.8 Intermediate Similarity NPC274330
0.8 Intermediate Similarity NPC290972
0.8 Intermediate Similarity NPC263393
0.8 Intermediate Similarity NPC143232
0.8 Intermediate Similarity NPC64872
0.8 Intermediate Similarity NPC127689
0.8 Intermediate Similarity NPC470588
0.8 Intermediate Similarity NPC476274
0.8 Intermediate Similarity NPC293048
0.8 Intermediate Similarity NPC35751
0.8 Intermediate Similarity NPC61543
0.8 Intermediate Similarity NPC121798
0.8 Intermediate Similarity NPC59263
0.8 Intermediate Similarity NPC270768
0.8 Intermediate Similarity NPC234346
0.8 Intermediate Similarity NPC198664
0.8 Intermediate Similarity NPC25906
0.8 Intermediate Similarity NPC117685
0.8 Intermediate Similarity NPC470906
0.8 Intermediate Similarity NPC73995
0.8 Intermediate Similarity NPC130520
0.8 Intermediate Similarity NPC471041
0.7981 Intermediate Similarity NPC89171
0.7981 Intermediate Similarity NPC476802
0.798 Intermediate Similarity NPC187933
0.798 Intermediate Similarity NPC10057

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC274417 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9022 High Similarity NPD7900 Approved
0.9022 High Similarity NPD7901 Clinical (unspecified phase)
0.8737 High Similarity NPD7902 Approved
0.8617 High Similarity NPD7748 Approved
0.8571 High Similarity NPD3573 Approved
0.8404 Intermediate Similarity NPD7515 Phase 2
0.828 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.8065 Intermediate Similarity NPD6409 Approved
0.8065 Intermediate Similarity NPD7334 Approved
0.8065 Intermediate Similarity NPD6684 Approved
0.8065 Intermediate Similarity NPD7146 Approved
0.8065 Intermediate Similarity NPD5330 Approved
0.8065 Intermediate Similarity NPD7521 Approved
0.8061 Intermediate Similarity NPD4697 Phase 3
0.7938 Intermediate Similarity NPD6399 Phase 3
0.7925 Intermediate Similarity NPD6650 Approved
0.7925 Intermediate Similarity NPD6649 Approved
0.7905 Intermediate Similarity NPD6372 Approved
0.7905 Intermediate Similarity NPD6373 Approved
0.7895 Intermediate Similarity NPD5737 Approved
0.7895 Intermediate Similarity NPD6672 Approved
0.7895 Intermediate Similarity NPD6903 Approved
0.7835 Intermediate Similarity NPD6079 Approved
0.7812 Intermediate Similarity NPD5328 Approved
0.781 Intermediate Similarity NPD6881 Approved
0.781 Intermediate Similarity NPD6899 Approved
0.7788 Intermediate Similarity NPD7128 Approved
0.7788 Intermediate Similarity NPD6008 Approved
0.7788 Intermediate Similarity NPD5739 Approved
0.7788 Intermediate Similarity NPD6675 Approved
0.7788 Intermediate Similarity NPD6402 Approved
0.7778 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7714 Intermediate Similarity NPD5697 Approved
0.7684 Intermediate Similarity NPD3618 Phase 1
0.7664 Intermediate Similarity NPD7290 Approved
0.7664 Intermediate Similarity NPD7102 Approved
0.7664 Intermediate Similarity NPD6883 Approved
0.7653 Intermediate Similarity NPD8034 Phase 2
0.7653 Intermediate Similarity NPD8035 Phase 2
0.7642 Intermediate Similarity NPD6011 Approved
0.7642 Intermediate Similarity NPD7320 Approved
0.7593 Intermediate Similarity NPD6847 Approved
0.7593 Intermediate Similarity NPD6617 Approved
0.7593 Intermediate Similarity NPD6869 Approved
0.7593 Intermediate Similarity NPD8130 Phase 1
0.7579 Intermediate Similarity NPD1694 Approved
0.757 Intermediate Similarity NPD6014 Approved
0.757 Intermediate Similarity NPD6012 Approved
0.757 Intermediate Similarity NPD6013 Approved
0.7547 Intermediate Similarity NPD5701 Approved
0.7525 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7525 Intermediate Similarity NPD7732 Phase 3
0.7525 Intermediate Similarity NPD5221 Approved
0.7525 Intermediate Similarity NPD5222 Approved
0.7523 Intermediate Similarity NPD6882 Approved
0.7523 Intermediate Similarity NPD8297 Approved
0.7451 Intermediate Similarity NPD5173 Approved
0.7449 Intermediate Similarity NPD6904 Approved
0.7449 Intermediate Similarity NPD6080 Approved
0.7449 Intermediate Similarity NPD6673 Approved
0.7447 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7431 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7379 Intermediate Similarity NPD7638 Approved
0.7327 Intermediate Similarity NPD6001 Approved
0.7321 Intermediate Similarity NPD6868 Approved
0.7308 Intermediate Similarity NPD4696 Approved
0.7308 Intermediate Similarity NPD7639 Approved
0.7308 Intermediate Similarity NPD5286 Approved
0.7308 Intermediate Similarity NPD5285 Approved
0.7308 Intermediate Similarity NPD7640 Approved
0.7282 Intermediate Similarity NPD4755 Approved
0.7282 Intermediate Similarity NPD6083 Phase 2
0.7282 Intermediate Similarity NPD6084 Phase 2
0.7273 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD7115 Discovery
0.7238 Intermediate Similarity NPD5223 Approved
0.7216 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD5696 Approved
0.7193 Intermediate Similarity NPD6335 Approved
0.7184 Intermediate Similarity NPD7614 Phase 1
0.7179 Intermediate Similarity NPD8328 Phase 3
0.7172 Intermediate Similarity NPD5208 Approved
0.717 Intermediate Similarity NPD5225 Approved
0.717 Intermediate Similarity NPD4633 Approved
0.717 Intermediate Similarity NPD5226 Approved
0.717 Intermediate Similarity NPD5211 Phase 2
0.717 Intermediate Similarity NPD5224 Approved
0.7168 Intermediate Similarity NPD6274 Approved
0.7143 Intermediate Similarity NPD4700 Approved
0.7143 Intermediate Similarity NPD6098 Approved
0.7143 Intermediate Similarity NPD4632 Approved
0.7143 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.713 Intermediate Similarity NPD7100 Approved
0.713 Intermediate Similarity NPD7101 Approved
0.7129 Intermediate Similarity NPD5693 Phase 1
0.7129 Intermediate Similarity NPD6050 Approved
0.7129 Intermediate Similarity NPD6411 Approved
0.7113 Intermediate Similarity NPD3668 Phase 3
0.7113 Intermediate Similarity NPD3665 Phase 1
0.7113 Intermediate Similarity NPD3133 Approved
0.7113 Intermediate Similarity NPD3666 Approved
0.7113 Intermediate Similarity NPD4786 Approved
0.7105 Intermediate Similarity NPD6317 Approved
0.7103 Intermediate Similarity NPD5174 Approved
0.7103 Intermediate Similarity NPD5175 Approved
0.7087 Intermediate Similarity NPD5695 Phase 3
0.7083 Intermediate Similarity NPD3667 Approved
0.7059 Intermediate Similarity NPD4202 Approved
0.7053 Intermediate Similarity NPD4695 Discontinued
0.7043 Intermediate Similarity NPD6313 Approved
0.7043 Intermediate Similarity NPD6314 Approved
0.7037 Intermediate Similarity NPD5141 Approved
0.703 Intermediate Similarity NPD5692 Phase 3
0.703 Intermediate Similarity NPD5207 Approved
0.7009 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.6961 Remote Similarity NPD5694 Approved
0.6957 Remote Similarity NPD6009 Approved
0.6947 Remote Similarity NPD7645 Phase 2
0.6944 Remote Similarity NPD4754 Approved
0.6942 Remote Similarity NPD7736 Approved
0.6937 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6931 Remote Similarity NPD6101 Approved
0.6931 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6319 Approved
0.6917 Remote Similarity NPD7507 Approved
0.6909 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6891 Remote Similarity NPD7604 Phase 2
0.6887 Remote Similarity NPD4225 Approved
0.6864 Remote Similarity NPD6909 Approved
0.6864 Remote Similarity NPD5983 Phase 2
0.6864 Remote Similarity NPD6908 Approved
0.6847 Remote Similarity NPD5128 Approved
0.6847 Remote Similarity NPD4730 Approved
0.6847 Remote Similarity NPD4729 Approved
0.6847 Remote Similarity NPD5168 Approved
0.6833 Remote Similarity NPD7492 Approved
0.6818 Remote Similarity NPD4768 Approved
0.6818 Remote Similarity NPD4767 Approved
0.6813 Remote Similarity NPD4691 Approved
0.6796 Remote Similarity NPD5281 Approved
0.6796 Remote Similarity NPD5284 Approved
0.6789 Remote Similarity NPD6052 Approved
0.678 Remote Similarity NPD6054 Approved
0.6777 Remote Similarity NPD6336 Discontinued
0.6777 Remote Similarity NPD6616 Approved
0.6765 Remote Similarity NPD4753 Phase 2
0.6762 Remote Similarity NPD5210 Approved
0.6762 Remote Similarity NPD4629 Approved
0.6757 Remote Similarity NPD6412 Phase 2
0.6757 Remote Similarity NPD6614 Approved
0.6748 Remote Similarity NPD7319 Approved
0.6735 Remote Similarity NPD4223 Phase 3
0.6735 Remote Similarity NPD4221 Approved
0.6726 Remote Similarity NPD5249 Phase 3
0.6726 Remote Similarity NPD5135 Approved
0.6726 Remote Similarity NPD5250 Approved
0.6726 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6726 Remote Similarity NPD5247 Approved
0.6726 Remote Similarity NPD5169 Approved
0.6726 Remote Similarity NPD5248 Approved
0.6726 Remote Similarity NPD4634 Approved
0.6726 Remote Similarity NPD5251 Approved
0.6726 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6721 Remote Similarity NPD7078 Approved
0.6703 Remote Similarity NPD4137 Phase 3
0.67 Remote Similarity NPD5329 Approved
0.6697 Remote Similarity NPD7632 Discontinued
0.6696 Remote Similarity NPD7094 Approved
0.6696 Remote Similarity NPD6858 Approved
0.6667 Remote Similarity NPD5217 Approved
0.6667 Remote Similarity NPD5127 Approved
0.6667 Remote Similarity NPD5215 Approved
0.6667 Remote Similarity NPD6370 Approved
0.6667 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5216 Approved
0.6639 Remote Similarity NPD6059 Approved
0.6634 Remote Similarity NPD5279 Phase 3
0.663 Remote Similarity NPD4747 Approved
0.6604 Remote Similarity NPD5654 Approved
0.6602 Remote Similarity NPD6051 Approved
0.66 Remote Similarity NPD4197 Approved
0.6596 Remote Similarity NPD4058 Approved
0.6585 Remote Similarity NPD8293 Discontinued
0.6583 Remote Similarity NPD6015 Approved
0.6583 Remote Similarity NPD6016 Approved
0.6571 Remote Similarity NPD5778 Approved
0.6571 Remote Similarity NPD5779 Approved
0.6559 Remote Similarity NPD5777 Approved
0.6549 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6549 Remote Similarity NPD6686 Approved
0.6531 Remote Similarity NPD7525 Registered
0.6529 Remote Similarity NPD5988 Approved
0.65 Remote Similarity NPD4788 Approved
0.6496 Remote Similarity NPD5167 Approved
0.6495 Remote Similarity NPD3617 Approved
0.6491 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6481 Remote Similarity NPD5959 Approved
0.6471 Remote Similarity NPD4138 Approved
0.6471 Remote Similarity NPD4688 Approved
0.6471 Remote Similarity NPD4623 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data